178 related articles for article (PubMed ID: 26633560)
21. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells.
Khan S; Abdelrahim M; Samudio I; Safe S
Endocrinology; 2003 Jun; 144(6):2325-35. PubMed ID: 12746293
[TBL] [Abstract][Full Text] [Related]
22. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.
Robitaille AM; Christen S; Shimobayashi M; Cornu M; Fava LL; Moes S; Prescianotto-Baschong C; Sauer U; Jenoe P; Hall MN
Science; 2013 Mar; 339(6125):1320-3. PubMed ID: 23429704
[TBL] [Abstract][Full Text] [Related]
23. Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer.
Rogers TM; Russell PA; Wright G; Wainer Z; Pang JM; Henricksen LA; Singh S; Stanislaw S; Grille J; Roberts E; Solomon B; Fox SB
J Thorac Oncol; 2015 Apr; 10(4):611-8. PubMed ID: 25789833
[TBL] [Abstract][Full Text] [Related]
24. Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence.
Morin A; Fritsch L; Mathieu JR; Gilbert C; Guarmit B; Firlej V; Gallou-Kabani C; Vieillefond A; Delongchamps NB; Cabon F
FASEB J; 2012 Jan; 26(1):460-7. PubMed ID: 21982950
[TBL] [Abstract][Full Text] [Related]
25. Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma.
Pacenta HL; Macy ME
Drug Des Devel Ther; 2018; 12():3549-3561. PubMed ID: 30425456
[TBL] [Abstract][Full Text] [Related]
26. Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib.
Wong HH; Bentley H; Bulusu VR; Anyaegbu G; Watkins J; Horan G; Hatcher H
Anticancer Drugs; 2020 Nov; 31(10):1106-1110. PubMed ID: 32868646
[TBL] [Abstract][Full Text] [Related]
27. Patterns of ALK expression in different human cancer types.
Tennstedt P; Strobel G; Bölch C; Grob T; Minner S; Masser S; Simon R
J Clin Pathol; 2014 Jun; 67(6):477-81. PubMed ID: 24478382
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning of a human cDNA encoding a trifunctional enzyme of carbamoyl-phosphate synthetase-aspartate transcarbamoylase-dihydroorotase in de Novo pyrimidine synthesis.
Iwahana H; Fujimura M; Ii S; Kondo M; Moritani M; Takahashi Y; Yamaoka T; Yoshimoto K; Itakura M
Biochem Biophys Res Commun; 1996 Feb; 219(1):249-55. PubMed ID: 8619816
[TBL] [Abstract][Full Text] [Related]
29. ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer.
Solomon B; Varella-Garcia M; Camidge DR
J Thorac Oncol; 2009 Dec; 4(12):1450-4. PubMed ID: 20009909
[TBL] [Abstract][Full Text] [Related]
30. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
To KF; Tong JH; Yeung KS; Lung RW; Law PP; Chau SL; Kang W; Tong CY; Chow C; Chan AW; Leung LK; Mok TS
J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
[TBL] [Abstract][Full Text] [Related]
31. A novel fusion of TPR and ALK in lung adenocarcinoma.
Choi YL; Lira ME; Hong M; Kim RN; Choi SJ; Song JY; Pandy K; Mann DL; Stahl JA; Peckham HE; Zheng Z; Han J; Mao M; Kim J
J Thorac Oncol; 2014 Apr; 9(4):563-6. PubMed ID: 24736082
[TBL] [Abstract][Full Text] [Related]
32. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
[TBL] [Abstract][Full Text] [Related]
33. Triacetyluridine treats epileptic encephalopathy from CAD mutations: a case report and review.
Frederick A; Sherer K; Nguyen L; Ali S; Garg A; Haas R; Sahagian M; Bui J
Ann Clin Transl Neurol; 2021 Jan; 8(1):284-287. PubMed ID: 33249780
[TBL] [Abstract][Full Text] [Related]
34. Entrectinib: A New Selective Tyrosine Kinase Inhibitor Approved for the Treatment of Pediatric and Adult Patients with NTRK Fusionpositive, Recurrent or Advanced Solid Tumors.
Osman HM; Tuncbilek M
Curr Med Chem; 2022; 29(15):2602-2616. PubMed ID: 34521321
[TBL] [Abstract][Full Text] [Related]
35. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
Gruber K; Horn H; Kalla J; Fritz P; Rosenwald A; Kohlhäufl M; Friedel G; Schwab M; Ott G; Kalla C
J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999
[TBL] [Abstract][Full Text] [Related]
36. Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer.
Russo M; Misale S; Wei G; Siravegna G; Crisafulli G; Lazzari L; Corti G; Rospo G; Novara L; Mussolin B; Bartolini A; Cam N; Patel R; Yan S; Shoemaker R; Wild R; Di Nicolantonio F; Bianchi AS; Li G; Siena S; Bardelli A
Cancer Discov; 2016 Jan; 6(1):36-44. PubMed ID: 26546295
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of cyclin D1 enhances gene amplification.
Zhou P; Jiang W; Weghorst CM; Weinstein IB
Cancer Res; 1996 Jan; 56(1):36-9. PubMed ID: 8548770
[TBL] [Abstract][Full Text] [Related]
38. Uridine treatment normalizes the congenital dyserythropoietic anemia type II-like hematological phenotype in a patient with homozygous mutation in the CAD gene.
Russo R; Marra R; Andolfo I; Manna F; De Rosa G; Rosato BE; Radhakrishnan K; Fahey M; Iolascon A
Am J Hematol; 2020 Nov; 95(11):1423-1426. PubMed ID: 32720728
[No Abstract] [Full Text] [Related]
39. NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line.
Lee SJ; Li GG; Kim ST; Hong ME; Jang J; Yoon N; Ahn SM; Murphy D; Christiansen J; Wei G; Hornby Z; Lee DW; Park JO; Park YS; Lim HY; Hong SN; Kim SH; Kang WK; Park K; Park WY; Kim KM; Lee J
Oncotarget; 2015 Nov; 6(36):39028-35. PubMed ID: 26472021
[TBL] [Abstract][Full Text] [Related]
40. Activity of Entrectinib in a Patient With the First Reported
Sigal D; Tartar M; Xavier M; Bao F; Foley P; Luo D; Christiansen J; Hornby Z; Maneval EC; Multani P
J Natl Compr Canc Netw; 2017 Nov; 15(11):1317-1322. PubMed ID: 29118225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
